Remix Therapeutics is a biotechnology company developing novel small molecule therapies designed to reprogram RNA processing and treat disease in entirely new ways.

Biotechnology

Health Care

Therapeutics

Remix Therapeutics

Peter Smith

Dominic Reynolds

Mark Scuzzarella

Silvia Buonamici

Rob Gagnon

Matthew Schnaderbeck

Cecile Blaustein

Heather Wasserman

The Advisory Team at Remix Therapeutics provides expert guidance on strategic decisions, scientific research, clinical development, and regulatory affairs. Comprised of industry leaders and subject matter experts, this team supports the company in advancing its RNA processing therapies from concept to market.

Advisory Team

Scientific Advisory Team

Scientific and Research Team

Advisory Team

About

Team members

Other teams at Remix Therapeutics

Scientific Advisory Team

Scientific and Research Team